Health ❯ Medicine

Oncology

Cancer Research Cancer Treatment Breast Cancer Brain Cancer Cancer Chemotherapy Prostate Cancer Cancer Biology Colorectal Cancer Lung Cancer Immunotherapy Cancer Types Pancreatic Cancer Tumor Biology Bone Cancer Brain Tumors Cancer Immunotherapy Skin Cancer Cancer Treatments Tumor Microenvironment Pediatric Oncology Types of Cancer Hematologic Cancers Blood Cancer Veterinary Oncology Cancer Diagnosis Leukemia Cancer Therapy Clinical Trials Gastric Cancer Cancer Risk Factors Multiple Myeloma Cancer Therapies Cancer Metabolism Melanoma Experts Hematological Malignancies Biomarkers Drug Development Tumors Genetics Pediatric Cancer Neuro-oncology Oncopathology Solid Tumors Cancer Vaccines Hematology Acute Myeloid Leukemia Colon Cancer Metastasis Patient Care Tumor Suppressors Cancer Detection Cancer Genetics Radiotherapy AML Cancer Treatment Innovations Cancer Prevention Bile Duct Cancer Upper Aerodigestive Tract Cancers Oral Cancer Cancer Incidence Carcinogens Breast Cancer Treatment Patient Outcomes Cholangiocarcinoma Cancer Awareness Cancer Research Institutions Early-Onset Cancer Cancer Misdiagnosis Precision Oncology Hematologic Malignancies Cancer Immunology Cancer Progression Clinical Research Ovarian Cancer Viral Oncology Neuro-Oncology Precision Medicine Renal Cancer Blood Cancers

Southampton Team Engineers Four-Pronged Antibodies to Boost T‑Cell Activation in Preclinical Cancer Tests

The four-pronged design clusters CD27 receptors to boost T‑cell activation in preclinical tests.

Amgen Buys Oxford Spinout Dark Blue Therapeutics for Up to $840 Million

Study Finds CBD–THC Combination Kills Ovarian Cancer Cells in Lab

Engineered Herpes Virus Shows Preclinical Gains Against Glioblastoma

Scientists Reveal How Gut Toxin Colibactin Cross-Links DNA in Colorectal Cancer

Crescent, Kelun-Biotech Trade Cancer Asset Rights in Cross-Border Deal as Crescent Secures $185 Million

Janux Plunges on Mixed Phase 1 Prostate Cancer Data for JANX007

Immune Cell Stress Switch Implicated in Chemo Neuropathy, With Existing Inhibitors Poised for Tests

Hydralazine Identified as ADO Inhibitor, Putting Glioblastoma Cells Into Senescence in Lab Study

CRISPR Knockout of NRF2 Reverses Chemotherapy Resistance in Lung Cancer Models

Merck to Buy Cidara for $9.2 Billion to Secure Long-Acting Flu Drug

Study Finds TGF-β Builds Dual Immune Barrier in Metastatic Colorectal Cancer

Triple Therapy Counters Endocrine Resistance in ER+ Breast Cancer in Preclinical Study

Targeted Nanoparticles Help Checkpoint Drugs Erase Ovarian Tumors in Mice

Study Ties CGRP–RAMP1 Signaling to GI Tumor Growth, Pointing to Repurposed Migraine Therapies

Takeda Strikes $11 Billion-Plus Oncology Deal With Innovent, Pays $1.2 Billion Upfront

mRNA COVID Vaccination Linked to Longer Survival With Cancer Immunotherapy, Data Presented at ESMO

HSF1-Driven Autophagy Found to Undercut Proteasome Drugs in AML, Preclinical Combo Shows Benefit

Tumor CRATERs Flag T-Cell Killing Hotspots and Track With Immunotherapy Response

Study Reveals How Tumor Bacteria Induce Quiescence to Thwart Cancer Treatment